DiaMedica Therapeutics (DMAC) Stock Chart & Stock Price History $6.86 -0.07 (-1.01%) Closing price 10/7/2025 04:00 PM EasternExtended Trading$6.86 +0.00 (+0.07%) As of 10/7/2025 05:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DiaMedica Therapeutics Stock Price Performance The DiaMedica Therapeutics (DMAC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 47.53%, with a year-to-date return of 26.34%. In the past month, the stock has decreased 4.19%, reflecting recent market activity. As of the latest close, DiaMedica Therapeutics traded at $6.86 with a market cap of $354.59 million and volume of 227,670 shares. Five years ago, the stock traded at $4.86, representing a 41.15% increase over that period. At the time, it had a market cap of $91.07 million and a volume of 61,901 shares. Receive DMAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-2.97%1 Month Performance-4.19%3 Month Performance+87.95%Year-To-Date Performance+26.34%1 Year Performance+47.53%5 Year Performance+41.15% DMAC Stock Chart for Wednesday, October, 8, 2025 DMAC Chart by TradingView DiaMedica Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/07/2025$6.93$6.86-1.01%$7.13$6.75227,670 shs$354.59 million10/06/2025$7.07$6.93-1.98%$7.14$6.91221,766 shs$358.21 million10/03/2025$7.00$7.07+1.00%$7.13$6.92229,505 shs$365.45 million10/02/2025$6.86$7.00+2.04%$7.03$6.80134,557 shs$361.83 million10/01/2025$6.87$6.86-0.15%$7.02$6.66183,911 shs$354.59 million09/30/2025$6.91$6.87-0.58%$7.03$6.80138,449 shs$355.11 million09/29/2025$6.94$6.91-0.43%$7.10$6.82218,900 shs$357.18 million09/26/2025$6.84$6.94+1.46%$6.95$6.72122,817 shs$358.73 million09/25/2025$6.85$6.84-0.15%$6.99$6.68167,511 shs$353.55 million09/24/2025$6.86$6.85-0.15%$6.98$6.75171,216 shs$354.08 million Get the Latest News and Ratings for DMAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/23/2025$6.98$6.86-1.72%$7.14$6.81471,952 shs$354.59 million09/22/2025$6.82$6.98+2.35%$7.17$6.65532,732 shs$360.79 million09/19/2025$6.76$6.82+0.89%$7.00$6.651.32 million shs$352.52 million09/18/2025$6.87$6.76-1.60%$7.08$6.76430,608 shs$349.42 million09/17/2025$6.97$6.87-1.43%$7.18$6.82392,060 shs$355.11 million09/16/2025$7.01$6.97-0.57%$7.19$6.95241,630 shs$360.27 million09/15/2025$7.09$7.01-1.13%$7.41$7.01396,783 shs$362.35 million09/12/2025$7.28$7.09-2.61%$7.35$7.05418,976 shs$366.48 million09/11/2025$7.13$7.28+2.10%$7.43$6.83766,653 shs$376.30 million09/10/2025$7.21$7.13-1.11%$7.46$7.08343,203 shs$368.54 million09/09/2025$7.16$7.21+0.70%$7.30$7.06442,927 shs$372.69 million09/08/2025$6.14$7.16+16.61%$7.49$6.572.13 million shs$370.10 million Related Companies Schrodinger Stock Price Chart AbCellera Biologics Stock Price Chart Janux Therapeutics Stock Price Chart Arcus Biosciences Stock Price Chart Syndax Pharmaceuticals Stock Price Chart Ardelyx Stock Price Chart Stoke Therapeutics Stock Price Chart Xeris Biopharma Stock Price Chart Zymeworks Stock Price Chart Amylyx Pharmaceuticals Stock Price Chart Receive DMAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DMAC) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | Sponsored"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DiaMedica Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
